Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Sato T, Coler-Reilly A, Utsunomiya A, Araya N, Yagishita N, Ando H, Yamauchi J, Inoue E, Ueno T, Hasegawa Y, Nishioka K, Nakajima T, Jacobson S, Izumo S, Yamano Y. Sato T, et al. Among authors: inoue e. PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2479. doi: 10.1371/journal.pntd.0002479. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24130912 Free PMC article.
Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study.
Martin F, Inoue E, Cortese IC, de Almeida Kruschewsky R, Adonis A, Grassi MF, Galvão-Castro B, Jacobson S, Yamano Y, Taylor GP, Bland M. Martin F, et al. Among authors: inoue e. Pilot Feasibility Stud. 2015 Oct 23;1:35. doi: 10.1186/s40814-015-0031-1. eCollection 2015. Pilot Feasibility Stud. 2015. PMID: 27965813 Free PMC article.
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
Coler-Reilly ALG, Sato T, Matsuzaki T, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Inoue E, Yamano Y. Coler-Reilly ALG, et al. Among authors: inoue e. Neurotherapeutics. 2017 Oct;14(4):1084-1094. doi: 10.1007/s13311-017-0533-z. Neurotherapeutics. 2017. PMID: 28536850 Free PMC article.
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Sato T, et al. Among authors: inoue e. N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827. N Engl J Med. 2018. PMID: 29414279 Free article. Clinical Trial.
Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Yamakawa N, Yagishita N, Matsuo T, Yamauchi J, Ueno T, Inoue E, Takata A, Nagasaka M, Araya N, Hasegawa D, Coler-Reilly A, Tsutsumi S, Sato T, Araujo A, Casseb J, Gotuzzo E, Jacobson S, Martin F, Puccioni-Sohler M, Taylor GP, Yamano Y; Japan Clinical Research Group on HAM/TSP. Yamakawa N, et al. Among authors: inoue e. Orphanet J Rare Dis. 2020 Jul 3;15(1):175. doi: 10.1186/s13023-020-01451-3. Orphanet J Rare Dis. 2020. PMID: 32620176 Free PMC article.
Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T, Takimoto T, Okita H, Tanaka Y, Inoue E, Oue T, Nozaki M, Tsuchiya K, Haruta M, Kaneko Y, Fukuzawa M. Koshinaga T, et al. Among authors: inoue e. Pediatr Int. 2019 Apr;61(4):351-357. doi: 10.1111/ped.13811. Epub 2019 Apr 16. Pediatr Int. 2019. PMID: 30786111 Clinical Trial.
527 results